drugset / Trial / NCT03884465
Hemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of Treprostinil
NaSequentialOpen-labelTreatment
Summary
Acute and chronic hemodynamic dose-response and safety evaluation of LIQ861 in PAH subjects.
Timeline
- Start
- 2019-11-11
- Primary completion
- 2020-12-23
- Completion
- 2020-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Treprostinil | Other / unclassified | 25 ug | Inhaled |
| Subject | Treprostinil | Other / unclassified | 50 ug | Inhaled |
| Subject | Treprostinil | Other / unclassified | 75 ug | Inhaled |
| Subject | Treprostinil | Other / unclassified | 100 ug | Inhaled |